Open AccessISCHEMIA – the Largest Ever R andomized Study in Stable Coronary Artery Disease. Baseline Characteristics of Enrolled Patients in One Russian Site
Author(s) -
L. L. Bershteyn,
Elizaveta V. Zbyshevskaya,
Nana O. Katamadze,
Anastasia M. KuzminaKrutetskaya,
А. В. Волков,
A. E. Andreeva,
V. E. Gumerova,
Fatima I. Bitakova,
S. A. Sayganov
Publication year - 2017
Publication title -
kardiologiia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.159
H-Index - 16
eISSN - 2412-5660
pISSN - 0022-9040
DOI - 10.18087/cardio.2017.10.10038
Subject(s) - medicine , cardiology , ejection fraction , coronary artery disease , revascularization , unstable angina , angina , stenosis , ischemia , myocardial infarction , heart failure
Indications for coronary revascularization in patients with stable coronary heart disease (CHD), presented in the current international guidelines are largely based on the clinical trials conducted sometimes more than 30 years ago. ISCHEMIA is the major multicenter international randomized trial intended to answer the question about the optimal treatment strategy in stable coronary artery disease at the present time.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom